Cancermuts
Cancermuts automates retrieval and annotation of cancer missense mutations from cBioPortal and COSMIC and annotates them with REVEL pathogenicity scores plus protein-context features such as post-translational modification sites, structured and unstructured regions, and short linear motifs to prioritize variants.
Key Features:
- Database integration: Retrieves known missense cancer mutations from cBioPortal and COSMIC and records mutation sources.
- Pathogenicity scoring: Annotates variants with REVEL pathogenicity scores.
- Protein-context annotation: Maps post-translational modification sites, structured and unstructured regions, and short linear motifs onto protein sequences.
- Contextual classification: Classifies mutations by REVEL score, sequence position, and local protein context.
- Analysis of intrinsically disordered proteins: Supports detailed annotation of intrinsically disordered proteins, exemplified by AMBRA1.
- Variant prioritization linked to experiments: Prioritized mutations that were experimentally validated, including two AMBRA1 variants with enhanced tumorigenic potential.
- Target-agnostic input: Operates starting from minimal information for any protein target.
Scientific Applications:
- Prioritization of pathogenic variants: Ranks missense mutations for downstream functional assessment in cancer genomics.
- Contextual functional interpretation: Assesses potential functional impact via proximity to PTMs, structured regions, disordered regions, and short linear motifs.
- Study of intrinsically disordered proteins: Enables analysis of mutation effects in proteins like AMBRA1 that contain disordered regions.
- Experimental candidate selection: Identifies mutations for cellular and molecular validation, including studies in melanoma.
Methodology:
Implemented in Python; retrieves mutations from cBioPortal and COSMIC; annotates variants with REVEL scores and mutation source; maps post-translational modification sites, structured/unstructured regions, and short linear motifs; and classifies mutations by REVEL score, sequence position, and local context.
Topics
Details
- License:
- GPL-3.0
- Cost:
- Free of charge
- Tool Type:
- library
- Operating Systems:
- Mac, Linux
- Programming Languages:
- Python
- Added:
- 12/23/2022
- Last Updated:
- 11/24/2024
Operations
Publications
Tiberti M, Di Leo L, Vistesen MV, Kuhre RS, Cecconi F, De Zio D, Papaleo E. The Cancermuts software package for the prioritization of missense cancer variants: a case study of AMBRA1 in melanoma. Cell Death & Disease. 2022;13(10). doi:10.1038/s41419-022-05318-2. PMID:36243772. PMCID:PMC9569343.